Skip to content

Clinical trials

Phase 2 Medulloblastoma trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Medulloblastoma Phase: Phase 2 Country / region: Canada Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20101
20133
20172
20181
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting4
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)6
Children's Oncology Group3
Children's Hospital Los Angeles1
Giselle Sholler1
Novartis Pharmaceuticals1
Ottawa Regional Cancer Centre1
Pfizer1
St. Jude Children's Research Hospital1
University of South Florida1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Medulloblastoma16
Central Nervous System Neoplasms10
Sarcoma6
Astrocytoma5
Neuroblastoma5
Brain Neoplasms4
Ependymoma4
Neuroectodermal Tumors, Primitive, Peripheral4
Optic Nerve Glioma4
Glioma3

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.